← All trials
NCT04157114
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 6, 2020
- Primary completion
- Jul 6, 2022
- Completion date
- Jul 6, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ScrippsLead sponsor
- MapregCollaborator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)Collaborator
- ScrippsReponsible party - principal investigator
- ScrippsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.